跳至主要内容
临床试验/NCT04771923
NCT04771923已完成不适用

Tranexamic Acid Versus Adrenaline for Controlling Iatrogenic Endobronchial Bleeding: a Double Blind, Randomized Controlled Trial

Clinical Hospital Centre Zagreb1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2021年2月22日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
130
试验地点
1
主要终点
Percentage (%) of successfully controlled iatrogenic endobronchial bleeding in each arm

研究概览

简要总结

Endobronchial bleeding is a relatively common complication of diagnostic bronchoscopy. Both tranexamic acid and adrenaline are used topically for the control of endobronchial bleeding. The aim of this study is to compare the efficacy of tranexamic acid with adrenaline in controlling iatrogenic endobronchial bleeding after diagnostic bronchoscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with endobronchial bleeding during diagnostic bronchoscopy that was not successfully controlled with cold (4°C) normal saline (3 aliquots of 5ml during 60sec)

排除标准

  • Any patient with a contraindication for diagnostic flexible bronchoscopy
  • Coagulopathy (PV INR >1.3)
  • Thrombocytopenia (<50x10^9) or anemia (hgb <80 g/L)
  • Direct oral anticoagulant, low molecular weight heparin or antiplatelet drug therapy
  • Thrombophilia, history of pulmonary embolism or deep vein thrombosis
  • Contraindication for endobronchial application of adrenaline
  • Coronary heart disease, cerebrovascular disease, history of tachyarrhythmia
  • Uncontrolled pulmonary hypertension
  • Cardiovascular decompensation
  • Severe hypoxia (PaO2 <60mmHg, SaO2 <90% with an FiO2 >=60%)

研究组 & 干预措施

Tranexamic acid

Experimental

干预措施: Tranexamic acid (Drug)

Adrenaline

Experimental

干预措施: Adrenaline (Drug)

结局指标

主要结局

Percentage (%) of successfully controlled iatrogenic endobronchial bleeding in each arm

时间窗: Until the end of the individual procedure (bronchoscopy), up to 1 minute after each drug application.

Bleeding control is assessed by the bronchoscopist by visual confirmation of clot formation.

次要结局

  • Number (N) of tranexamic acid/adrenaline applications necessary to control endobronchial bleeding(Until the end of the individual procedure (bronchoscopy), up to 1 minute after each drug application..)
  • Number (N) of recurrent bleeding episodes after instillation of tranexamic acid/adrenaline(During the first 24 hours immediately after the individual procedure (bronchoscopy).)
  • To compare number (N) of adverse events in each arm(During and up to 1 month after the procedure (bronchoscopy).)
  • Percentage (%) of successfully controlled iatrogenic endobronchial bleeding in each arm in relation to the severity of bleeding.(Until the end of the individual procedure (bronchoscopy), up to 1 minute after each drug application..)
  • Percentage (%) of successfully controlled iatrogenic endobronchial bleeding in each arm(Until the end of the individual procedure (bronchoscopy), up to 1 minute after each drug application.)

研究者

发起方
Clinical Hospital Centre Zagreb
申办方类型
Other
责任方
Principal Investigator
主要研究者

Goran Glodić

MD

Clinical Hospital Centre Zagreb

研究点 (1)

Loading locations...

相似试验